DOI:
10.1055/s-00000030
Der Klinikarzt
LinksClose Window
References
Ito M, Abe M, Okada K et al.
The dipeptidyl peptidase-4 (DPP-4) inhibitor vildagliptin improves glycemic control in type 2 diabetic patients undergoing hemodialysis.
Endocr J 2011;
58: 979-987
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.